Cargando…

A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL)

Genomic instability is a hallmark of cancer and an enabling factor for genetic alterations that drive cancer development and progression. The clashing of mitosis and aberrantly expressed meiosis machineries, which may contribute to genomic instability, has been coined cancer “meiomitosis”. LINE-1 re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsang, Matthew, Gantchev, Jennifer, Netchiporouk, Elena, Moreau, Linda, Ghazawi, Feras M., Glassman, Steven, Sasseville, Denis, Litvinov, Ivan V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340880/ https://www.ncbi.nlm.nih.gov/pubmed/30701021 http://dx.doi.org/10.18632/oncotarget.26479

Ejemplares similares

Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL)
por: Ghazawi, Feras M., et al.
Publicado: (2019)

The Ectopic Expression of Meiosis Regulatory Genes in Cutaneous T-Cell Lymphomas (CTCL)
por: Gantchev, Jennifer, et al.
Publicado: (2019)

Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1(+) leukemic cell lines
por: Netchiporouk, Elena, et al.
Publicado: (2017)

Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155
por: Litvinov, Ivan V, et al.
Publicado: (2013)

Cutaneous T-cell lymphoma developing in surgical scars post cardiac surgery: A case study
por: Touyz, Sarah J, et al.
Publicado: (2023)

Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries
por: Litvinov, Ivan V, et al.
Publicado: (2015)

Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients
por: Bagdonaite, Ieva, et al.
Publicado: (2015)

Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat
por: Duvic, Madeleine, et al.
Publicado: (2007)

Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population‐based study
por: Cattelan, Leila, et al.
Publicado: (2019)

28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
por: Garcia-Saleem, Tiffany J., et al.
Publicado: (2021)

The Skin Microbiome in Cutaneous T-Cell Lymphomas (CTCL)—A Narrative Review
por: Łyko, Magdalena, et al.
Publicado: (2022)

TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform
por: Lefrançois, Philippe, et al.
Publicado: (2017)

Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma
por: Gill, Raman Preet Kaur, et al.
Publicado: (2022)

Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada
por: Cattelan, Leila, et al.
Publicado: (2021)

Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
por: Denis, Daphné, et al.
Publicado: (2019)

JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
por: Vadivel, Chella Krishna, et al.
Publicado: (2021)

Safety and danger of biologic treatments in psoriasis in context of cutaneous T-cell lymphoma (CTCL)
por: Kołkowski, Karol, et al.
Publicado: (2021)

Cutaneous T-cell lymphoma (CTCL) exacerbation after viral vector COVID-19 vaccination
por: Panou, Evdoxia, et al.
Publicado: (2021)

Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada
por: Conte, Santina, et al.
Publicado: (2022)

Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in Canada
por: Berman-Rosa, Melissa, et al.
Publicado: (2022)

Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
por: Lagacé, François, et al.
Publicado: (2021)

International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19
por: Geskin, Larisa J, et al.
Publicado: (2021)

NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib
por: KieΔling, Michael K., et al.
Publicado: (2017)

Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries
por: Assaf, Chalid, et al.
Publicado: (2021)

The Importance of Excluding Cutaneous T-Cell Lymphomas in Patients with a Working Diagnosis of Papuloerythroderma of Ofuji: A Case Series
por: Maher, Anthony M., et al.
Publicado: (2018)

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)
por: Petersen, D L, et al.
Publicado: (2014)

Synergistic cytotoxic activity of cannabinoids from cannabis sativa against cutaneous T-cell lymphoma (CTCL) in-vitro and ex-vivo
por: Mazuz, Moran, et al.
Publicado: (2020)

Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description
por: D’Agostino, Paolo, et al.
Publicado: (2020)

Targeting the non‐ATP‐binding pocket of the MAP kinase p38γ mediates a novel mechanism of cytotoxicity in cutaneous T‐cell lymphoma (CTCL)
por: Zhang, Xu Hannah, et al.
Publicado: (2021)

Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells
por: Marzec, Michal, et al.
Publicado: (2011)

Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
por: Crimp, Caitlin, et al.
Publicado: (2022)

National trends in incidence and geographic distribution of melanoma and keratinocyte carcinoma in the Russian Federation
por: Muntyanu, Anastasiya, et al.
Publicado: (2023)

Editorial: The Emerging Role of Artificial Intelligence in Dermatology
por: Mahmood, Farhan, et al.
Publicado: (2021)

Retraction: Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells
Publicado: (2020)

CCR4‐IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T‐cell lymphoma in a mouse CTCL model
por: Wang, Zhaohui, et al.
Publicado: (2023)

Cutaneous Squamous Cell Carcinoma in Patients with Hidradenitis Suppurativa
por: Racanelli, Elysia, et al.
Publicado: (2021)

Uveal melanoma incidence trends in Canada: 1992–2010 vs. 2011–2017
por: Conte, Santina, et al.
Publicado: (2023)

Investigation of incidence and geographic distribution of gliomas in Canada from 1992 to 2010: a national population-based study highlighting the importance of exposure to airport operations
por: Ji, Xinyu, et al.
Publicado: (2023)

Brentuximab vedotin: targeting CD30 as standard in CTCL
por: Prince, H. Miles, et al.
Publicado: (2018)

Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients
por: Martínez Villarreal, Amelia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iphc81lv8j0t5hmodkp57i767c